Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The FEBS Journal
|
July 30, 2021
PRL-3 promotes a positive feedback loop between STAT1/2-induced gene expression and glycolysis in multiple myeloma
Caroline N Smith, Jessica S Blackburn
Methods in Molecular Biology (Clifton, N.J.)
|
December 26, 2023
Examining Phosphatases Through Immunofluorescent Microscopy
Caroline N Smith, Jessica S Blackburn
Journal of Public Health Management and Practice : JPHMP
|
August 30, 2022
The Ever-Evolving Nature of Health Literacy in Organizations: A Commentary on the 2021 JPHMP Article "Updating Health Literacy for Healthy People 2030"
Caroline N Smith, Paul Gorczynski, Jafrā D Thomas
Scientific Reports
|
May 14, 2021
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Dylan R Rivas, Mark Vincent C Dela Cerna, Caroline N Smith, et al.
Plos One
|
May 23, 2023
Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3
Caroline N Smith, Kyle Kihn, Zachary A Williamson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The FEBS Journal
|
July 30, 2021
PRL-3 promotes a positive feedback loop between STAT1/2-induced gene expression and glycolysis in multiple myeloma
Caroline N Smith, Jessica S Blackburn
Methods in Molecular Biology (Clifton, N.J.)
|
December 26, 2023
Examining Phosphatases Through Immunofluorescent Microscopy
Caroline N Smith, Jessica S Blackburn
Journal of Public Health Management and Practice : JPHMP
|
August 30, 2022
The Ever-Evolving Nature of Health Literacy in Organizations: A Commentary on the 2021 JPHMP Article "Updating Health Literacy for Healthy People 2030"
Caroline N Smith, Paul Gorczynski, Jafrā D Thomas
Scientific Reports
|
May 14, 2021
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Dylan R Rivas, Mark Vincent C Dela Cerna, Caroline N Smith, et al.
Plos One
|
May 23, 2023
Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3
Caroline N Smith, Kyle Kihn, Zachary A Williamson, et al.
Page
of 1